GALT
Price
$3.37
Change
-$0.06 (-1.75%)
Updated
Oct 21 closing price
Capitalization
339.86M
22 days until earnings call
Intraday BUY SELL Signals
ZURA
Price
$4.13
Change
+$0.13 (+3.25%)
Updated
Oct 21 closing price
Capitalization
395.77M
21 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GALT vs ZURA

GALT vs ZURA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GALT vs. ZURA commentary
Oct 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GALT is a StrongBuy and ZURA is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for GALT with price predictions
Oct 21, 2026

GALT's Indicator enters downward trend

The Aroon Indicator for GALT entered a downward trend on October 21, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 273 similar instances where the Aroon Indicator formed such a pattern. In 248 of the 273 cases the stock moved lower. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GALT as a result. In 83 of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.

GALT moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for GALT crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GALT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +8.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where GALT advanced for three days, in 193 of 231 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

GALT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-2.444) is normal, around the industry mean (2.988). P/E Ratio (-7.837) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. GALT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GALT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for ZURA with price predictions
Oct 21, 2026

ZURA sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for ZURA moved below the 200-day moving average on October 02, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ZURA as a result. In 52 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.

The 10-day moving average for ZURA crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ZURA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

ZURA broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ZURA entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ZURA's RSI Oscillator exited the oversold zone, 19 of 23 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Moving Average Convergence Divergence (MACD) for ZURA just turned positive on October 07, 2026. Looking at past instances where ZURA's MACD turned positive, the stock continued to rise in 41 of 60 cases over the following month. The odds of a continued upward trend are 68%.

Following a +8.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where ZURA advanced for three days, in 152 of 187 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 29 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.008) is normal, around the industry mean (2.988). P/E Ratio (-3.688) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. ZURA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ZURA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
GALT: Fundamental Ratings
GALT
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
24
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GALTZURA
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
68%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
63%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
74%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
55%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
COMPARISON
Comparison
Oct 22, 2026
Stock price -- (GALT: $3.37 vs. ZURA: $4.13)
Brand notoriety: GALT and ZURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GALT: 103% vs. ZURA: 125%
Market capitalization -- GALT: $339.86M vs. ZURA: $395.77M
GALT [@Biotechnology] is valued at $339.86M. ZURA’s [@Biotechnology] market capitalization is $395.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $132.95B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GALT’s FA Score shows that 2 FA rating(s) are green while ZURA’s FA Score has 2 green FA rating(s).

  • GALT’s FA Score: 2 green, 3 red.
  • ZURA’s FA Score: 2 green, 3 red.
According to our system of comparison, both GALT and ZURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GALT’s TA Score shows that 3 TA indicator(s) are bullish while ZURA’s TA Score has 4 bullish TA indicator(s).

  • GALT’s TA Score: 3 bullish, 5 bearish.
  • ZURA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both GALT and ZURA are a bad buy in the short-term.

Price Growth

GALT (@Biotechnology) experienced а -7.42% price change this week, while ZURA (@Biotechnology) price change was -6.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.90%. For the same industry, the average monthly price growth was -15.91%, and the average quarterly price growth was -14.30%.

Reported Earning Dates

GALT is expected to report earnings on Nov 13, 2026.

ZURA is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (+1.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
GALT
Daily Signal:
Gain/Loss:
ZURA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
MINA.X0.0739680.002420
+3.38%
Mina cryptocurrency
CYBER.X0.3286850.007381
+2.30%
Cyber cryptocurrency
GFT.X0.000044N/A
+0.69%
Gifto cryptocurrency
BAR.X0.267393-0.000444
-0.17%
FC Barcelona Fan Token cryptocurrency
WLD.X0.582511-0.005471
-0.93%
Worldcoin cryptocurrency

GALT and

Correlation & Price change

A.I.dvisor tells us that GALT and ALT have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GALT and ALT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GALT
1D Price
Change %
GALT100%
-1.75%
ALT - GALT
33%
Poorly correlated
-3.04%
TAOX - GALT
32%
Poorly correlated
+4.88%
RNAC - GALT
32%
Poorly correlated
+0.39%
ZURA - GALT
30%
Poorly correlated
+3.25%
ACRV - GALT
29%
Poorly correlated
+1.67%
More

ZURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZURA has been loosely correlated with VIR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ZURA jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZURA
1D Price
Change %
ZURA100%
+3.25%
VIR - ZURA
44%
Loosely correlated
-1.58%
RCUS - ZURA
42%
Loosely correlated
-19.58%
TNXP - ZURA
41%
Loosely correlated
-6.06%
FDMT - ZURA
39%
Loosely correlated
-3.66%
AURA - ZURA
39%
Loosely correlated
-1.52%
More